Sanjeev Kumar Singh (Sanjeev K Singh)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Journal of cellular biochemistry

Scientific reports

PloS one

Journal of biomolecular structure & dynamics

Alagappa University

Chhatrapati Shahu Ji Maharaj University, (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Alagappa University Mar 20 2009

India

Professor :: Bioinformatics

Madurai Kamaraj University

India

Research Scientist :: Bioinformatics Centre

National Institute of Pharmaceutical Education and Research

India

Scientist - II :: Pharmacoinformatics

Education History

Chhatrapati Shahu Ji Maharaj University,

India

PHD :: Applied Chemistry

Chhatrapati Shahu Ji Maharaj University

India

MSC :: Life Sciences

Publications

Anuraj Nayarisseri, Mohnad Abdalla, Isha Joshi, Manasi Yadav, Anushka Bhrdwaj, Ishita Chopra, Arshiya Khan, Arshiya Saxena, Khushboo Sharma, Aravind Panicker, Umesh Panwar, Francisco Jaime Bezerra Mendonça Junior, Sanjeev Kumar Singh
Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer. Scientific reports 14 (1) (2024)
Anuraj Nayarisseri, Mohnad Abdalla, Isha Joshi, Manasi Yadav, Anushka Bhrdwaj, Ishita Chopra, Arshiya Khan, Arshiya Saxena, Khushboo Sharma, Aravind Panicker, Umesh Panwar, Francisco Jaime Bezerra Mendonça Junior, Sanjeev Kumar Singh
Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer. Scientific reports 14 (1) (2024)
Anuraj Nayarisseri, Mohnad Abdalla, Isha Joshi, Manasi Yadav, Anushka Bhrdwaj, Ishita Chopra, Arshiya Khan, Arshiya Saxena, Khushboo Sharma, Aravind Panicker, Umesh Panwar, Francisco Jaime Bezerra Mendonça Junior, Sanjeev Kumar Singh
Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer. Scientific reports 14 (1) (2024)
Anuraj Nayarisseri, Mohnad Abdalla, Isha Joshi, Manasi Yadav, Anushka Bhrdwaj, Ishita Chopra, Arshiya Khan, Arshiya Saxena, Khushboo Sharma, Aravind Panicker, Umesh Panwar, Francisco Jaime Bezerra Mendonça Junior, Sanjeev Kumar Singh
Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer. Scientific reports 14 (1) (2024)
Aarthy Murali, Umesh Panwar, Sanjeev Kumar Singh
Exploring the Role of Chemoinformatics in Accelerating Drug Discovery: A Computational Approach. Methods in molecular biology (Clifton, N.J.) 2714 (2023)
Khushboo Sharma, Umesh Panwar, Maddala Madhavi, Isha Joshi, Ishita Chopra, Lovely Soni, Arshiya Khan, Anushka Bhrdwaj, Abhyuday Singh Parihar, Vineeth Pazharathu Mohan, Leena Prajapati, Rashmi Sharma, Shweta Agrawal, Tajamul Hussain, Anuraj Nayarisseri, Sanjeev Kumar Singh
Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment. Medicinal chemistry (Shariqah (United Arab Emirates)) (2023)
Anuraj Nayarisseri, Sanjeev Kumar Singh
Genome analysis of biosurfactant producing bacterium, Bacillus tequilensis. PloS one 18 (6) (2023)
Umesh Panwar, Aarthy Murali, Mohammad Aqueel Khan, Chandrabose Selvaraj, Sanjeev Kumar Singh
Virtual Screening Process: A Guide in Modern Drug Designing. Methods in molecular biology (Clifton, N.J.) 2714 (2023)
Aarthy Murali, Sushil Kumar, Srinivasan Akshaya, Sanjeev Kumar Singh
Drug repurposing toward the inhibition of RNA-dependent RNA polymerase of various flaviviruses through computational study. Journal of cellular biochemistry 124 (1) (2022)
Aarthy Murali, Sushil Kumar, Srinivasan Akshaya, Sanjeev Kumar Singh
Drug repurposing toward the inhibition of RNA-dependent RNA polymerase of various flaviviruses through computational study. Journal of cellular biochemistry (2022)
Aarthy Murali, Sushil Kumar, Srinivasan Akshaya, Sanjeev Kumar Singh
Drug repurposing toward the inhibition of RNA-dependent RNA polymerase of various flaviviruses through computational study. Journal of cellular biochemistry 124 (1) (2022)
Aarthy Murali, Sushil Kumar, Srinivasan Akshaya, Sanjeev Kumar Singh
Drug repurposing toward the inhibition of RNA-dependent RNA polymerase of various flaviviruses through computational study. Journal of cellular biochemistry 124 (1) (2022)
Mohammad Aqueel Khan, Sanjeev Kumar Singh
Atom-based 3D-QSAR and DFT analysis of 5-substituted 2-acylaminothiazole derivatives as HIV-1 latency-reversing agents. Journal of biomolecular structure & dynamics (2022)
Chirasmita Nayak, Sanjeev Kumar Singh
Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis. ACS omega 7 (26) (2022)
Aarthy Murali, Sushil Kumar, Srinivasan Akshaya, Sanjeev Kumar Singh
Drug repurposing toward the inhibition of RNA-dependent RNA polymerase of various flaviviruses through computational study. Journal of cellular biochemistry 124 (1) (2022)
Murali Aarthy, Sanjeev Kumar Singh
Interpretations on the Interaction between Protein Tyrosine Phosphatase and E7 Oncoproteins of High and Low-Risk HPV: A Computational Perception. ACS omega 6 (25) (2021)
Chirasmita Nayak, Sanjeev Kumar Singh
In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells. PloS one 16 (10) (2021)
Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Umesh Panwar, Rajaram Abhirami, Evzen Boura, Sanjeev Kumar Singh
Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19. Journal of biomolecular structure & dynamics 39 (13) (2020)
Chirasmita Nayak, Ishwar Chandra, Sanjeev Kumar Singh
An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV-1 protease variants. Journal of cellular biochemistry 120 (6) (2018)
Srinivas Bandaru, Mallika Alvala, Anuraj Nayarisseri, Saphy Sharda, Himshikha Goud, Hema Prasad Mundluru, Sanjeev Kumar Singh
Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor. PloS one 12 (10) (2017)

Sanjeev Kumar Singh.css-eqlu8i{font-size:small;padding-left:4px;} (Sanjeev K Singh)

Publication Activity (10 Years)

Top Topics

Top Venues

Sanjeev Kumar Singh (Sanjeev K Singh)